High-quality Self-testing Kit with Result in 15 Minutes The Roche SARS-CoV-2 Antigen Self Test Nasal provides reliable and easy home testing for symptomatic and asymptomatic individuals suspected of having COVID-19. With results ready in 15 minutes, this self-use test kit allows users to make informed decisions including rapid isolation. Features – Rapid result: Results ready in 15 minutes – Easy interpretation: No instrument is required to read the results – Convenient sampling: Simple testing procedure with nasal specimen collection – Individually packed: Hygienic and ready for use – Reliable performance: High sensitivity and specificity (PPA: 91.1%, NPA: 99.6%) Intended Use The Roche COVID-19 Rapid Antigen Test is intended for over-the-counter (OTC) use and other non-laboratory sites. Interpretation of Results COVID-19 positive: both control line C and test line T are visible COVID-19 negative: Only the control line C is visible Invalid Test: No visible line or only the test line T is visible Authorization: Health Canada under Interim Order (#333956), TGA (Australia), HSA under PSAR (Singapore), FDA/EUA, EU, UK, Hong Kong Made in: Korea It is designed as a self‑test for patients. For best performance, it is recommended this test be used within 7 days post-onset of symptoms. Any COVID-19 variants in circulation as of 29 November 2021 (including the Delta variant) are detected by this test without any impact on performance. Each Kit Contains: 5 x Test devices (individually in foil pouch with desiccant) 5 x Extraction buffer tubes 5 x Nozzle caps 5 x Sterile swabs 1 x Tube holder 1 x Instructions for use 1 x Quick reference guide

High-quality Self-testing Kit with Result in 15 Minutes The Roche SARS-CoV-2 Antigen Self Test Nasal provides reliable and easy home testing for symptomatic and asymptomatic individuals suspected of having COVID-19. With results ready in 15 minutes, this self-use test kit allows users to make informed decisions including rapid isolation. Features – Rapid result: Results ready in 15 minutes – Easy interpretation: No instrument is required to read the results – Convenient sampling: Simple testing procedure with nasal specimen collection – Individually packed: Hygienic and ready for use – Reliable performance: High sensitivity and specificity (PPA: 91.1%, NPA: 99.6%) Intended Use The Roche COVID-19 Rapid Antigen Test is intended for over-the-counter (OTC) use and other non-laboratory sites. Interpretation of Results COVID-19 positive: both control line C and test line T are visible COVID-19 negative: Only the control line C is visible Invalid Test: No visible line or only the test line T is visible Authorization: Health Canada under Interim Order (#333956), TGA (Australia), HSA under PSAR (Singapore), FDA/EUA, EU, UK, Hong Kong Made in: Korea It is designed as a self‑test for patients. For best performance, it is recommended this test be used within 7 days post-onset of symptoms. Any COVID-19 variants in circulation as of 29 November 2021 (including the Delta variant) are detected by this test without any impact on performance. Each Kit Contains: 5 x Test devices (individually in foil pouch with desiccant) 5 x Extraction buffer tubes 5 x Nozzle caps 5 x Sterile swabs 1 x Tube holder 1 x Instructions for use 1 x Quick reference guide

High-quality Self-testing Kit with Result in 15 Minutes The Roche SARS-CoV-2 Antigen Self Test Nasal provides reliable and easy home testing for symptomatic and asymptomatic individuals suspected of having COVID-19. With results ready in 15 minutes, this self-use test kit allows users to make informed decisions including rapid isolation. Features – Rapid result: Results ready in 15 minutes – Easy interpretation: No instrument is required to read the results – Convenient sampling: Simple testing procedure with nasal specimen collection – Individually packed: Hygienic and ready for use – Reliable performance: High sensitivity and specificity (PPA: 91.1%, NPA: 99.6%) Intended Use The Roche COVID-19 Rapid Antigen Test is intended for over-the-counter (OTC) use and other non-laboratory sites. Interpretation of Results COVID-19 positive: both control line C and test line T are visible COVID-19 negative: Only the control line C is visible Invalid Test: No visible line or only the test line T is visible Authorization: Health Canada under Interim Order (#333956), TGA (Australia), HSA under PSAR (Singapore), FDA/EUA, EU, UK, Hong Kong Made in: Korea It is designed as a self‑test for patients. For best performance, it is recommended this test be used within 7 days post-onset of symptoms. Any COVID-19 variants in circulation as of 29 November 2021 (including the Delta variant) are detected by this test without any impact on performance. Each Kit Contains: 5 x Test devices (individually in foil pouch with desiccant) 5 x Extraction buffer tubes 5 x Nozzle caps 5 x Sterile swabs 1 x Tube holder 1 x Instructions for use 1 x Quick reference guide